• IQVIA, NVIDIA Build AI Agents for Clinical Research

    Jun 11 | Clinical Research News | Today, IQVIA announced multiple AI orchestrator agents in collaboration with NVIDIA. These specialized agentic systems—covering trial start-up, target identification, clinical data review, and more—are designed to manage and accelerate drug development workflows for IQVIA customers. More

  • Clinical Research Reveals Third Castleman Disease Subtype After 45 Years

    Jun 10 | Clinical Research News | Researchers have made a landmark discovery in rare disease clinical research by identifying a new subtype of Castleman disease, marking the first major advancement in disease classification since the 1970s. The breakthrough demonstrates how patient-driven research registries can overcome traditional barriers in rare disease studies to generate clinically meaningful insights. More

  • Bridging the Gap Between GI Research and Routine Practice

    Jun 06 | Clinical Research News | Gastroenterology is seeing meaningful progress in clinical research. New therapies for inflammatory bowel disease, colorectal cancer, and metabolic dysfunction-associated steatohepatitis (MASH) are being developed with increasing speed and precision. Yet for many community-based practices, participating in that research remains a significant challenge. More

  • Smart Bandage Technology Advances from Animal Models to Human Clinical Testing

    Jun 04 | Clinical Research News | California Institute of Technology researchers have successfully transitioned their innovative "smart bandage" technology from preclinical animal studies to human clinical testing, marking a significant milestone in the development of real-time wound monitoring systems for chronic wound management. More

  • Many Approaches Collectively Aim at a Cure for Myeloma

    Jun 03 | Clinical Research News | A small not-for-profit organization has set itself up as a model for turning the nitty-gritty of scientific research into a metaphorical “black swan event” with major impact on the lives of patients living with an incurable disease. The overarching strategy of the International Myeloma Foundation (IMF) is to function as the convener of the broader myeloma community in ways that lead to improved outcomes for patients in terms of both their quality and quantity of life. More

  • Follow the Money: PhaseV’s AI for Holistic Solutions, Carta’s AI Platform Transforms Clinical Data, More

    May 30 | Clinical Research News | PhaseV intends to grow its vertical AI platform to provide holistic solutions for clinical development; Carta Healthcare is expanding to meet the surging demands among health systems and life sciences organizations for AI-driven innovation that can transform clinical data into valuable insights; and more. More

  • Weill Cornell, Regeneron’s New AI, Elsevier Adds Half a Million Records, More

    May 29 | Clinical Research News | Weill Cornell Medicine and Regeneron Pharmaceuticals collaborated to develop a new AI-based method accurately sorts cancer patients into groups that have similar characteristics before treatment and similar outcomes after treatment; Elsevier announced the addition of half a million records from ClinicalTrials.gov to its leading biomedical literature database, Embase; and more. More

  • SCOPE 2025 Names West Clinical Research, Stitch as Site Innovation Award Winners

    May 23 | Clinical Research News | West Clinical Research (WCR) and Stitch were named the Site Innovation Award winners at this year’s SCOPE Summit in Orlando. The Site Innovation Award at SCOPE recognizes sites and partnerships pioneering new approaches to improve clinical trials. WCR and Stitch’s collaboration produced a platform, also called Stitch, that is designed to optimize trial participants’ experiences while also improving other aspects of trial participation and for site staff labor. More

  • Multi-Center Study Validates AI Tools for Precision Cancer Diagnostics

    May 21 | Clinical Research News | A clinical research initiative has demonstrated that artificial intelligence could significantly enhance the identification of patients eligible for targeted breast cancer therapies, according to preliminary findings presented by Friends of Cancer Research. More

  • The Scope of Things: Tackling Misinformation, Updated Guidelines to Clinical Trial Reports, More

    May 20 | Clinical Research News | This month at the Scope of Things, host Deborah Borfitz gives you the latest news on a precision medicine initiative in Sweden integrating research with healthcare, guideline updates on the reporting of clinical trials, and more. Briony Swire-Thompson, director of the Psychology of Misinformation Lab at Northeastern University Network Science Institute, also joins in to discuss the current misinformation epidemic and how clinical trials and sites can best deal with it. More
View more articles
 
DXX-Industry-spotlight
SOT

The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News Senior writer Deborah Borfitz welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.

Read More